• Health & Medicine

Let's get to the bottom of it – 7 common cancer myths, unpicked

There are cancer myths and misconceptions about bras, deodorant, 5G, mobile phones, diet and more. Here's what the evidence actually shows. There are cancer myths and misconceptions about bras, deodorant, 5G, mobile phones, diet and more. Here's what the evidence actually shows.

19 July 2023

• For Researchers

Moving target – retrotransposable elements and cancer

Links between retrotransposable elements and cancer have deep roots – George Kassiotis gets into their chequered past and how we might utilise these ancient viral infections   Links between retrotransposable elements and cancer have deep roots – George Kassiotis gets into their chequered past and how we might utilise these ancient viral infections  

11 July 2023

• Health & Medicine

Celebrating 75 years of NHS cancer care

To celebrate 75 years of the NHS, we’ve put together a timeline showing some of its biggest contributions to cancer care.   To celebrate 75 years of the NHS, we’ve put together a timeline showing some of its biggest contributions to cancer care.  

5 July 2023

• For Researchers

Therapeutic radiography: where theory meets practice

Therapeutic radiography is taking advantage of its position at the intersection of science and clinical delivery to deliver impactful research. Therapeutic radiography is taking advantage of its position at the intersection of science and clinical delivery to deliver impactful research.

3 July 2023

• For Researchers

A new culture – how CRUK is helping to take organoids global

Cancer patient-derived organoids from Japan’s Fukushima Medical University have become the latest technology to be made available via CancerTools.org Cancer patient-derived organoids from Japan’s Fukushima Medical University have become the latest technology to be made available via CancerTools.org

19 June 2023

• Science & Technology

Wasting syndrome: What is cachexia?

Cachexia is a complex syndrome which has puzzled researchers for decades. But with new research from Cancer Grand Challenges, we could be close to uncovering its mysteries. Cachexia is a complex syndrome which has puzzled researchers for decades. But with new research from Cancer Grand Challenges, we could be close to uncovering its mysteries.

19 June 2023

• For Researchers

Pearls of Grand Challenge wisdom

We hear from two Cancer Grand Challenges team leads with their thoughts on forming and running a team. We hear from two Cancer Grand Challenges team leads with their thoughts on forming and running a team.

16 June 2023

• Health & Medicine

Risk of dying from early invasive breast cancer down by around two-thirds in the last 20 years

Today, more than 90% of women diagnosed with early-stage breast cancer will survive for 5 years or more, according to research we funded. Today, more than 90% of women diagnosed with early-stage breast cancer will survive for 5 years or more, according to research we funded.

13 June 2023

• Health & Medicine

Age: the forgotten cancer risk factor?

Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight.  Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight. 

29 May 2023

• Science & Technology
• Health & Medicine

Stopping neuropathy – one of chemotherapy’s most challenging side effects

Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that. Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that.

22 May 2023

• Health & Medicine

FOCUS4: Learning from a landmark clinical trial

FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again.  FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again. 

25 April 2023

• Science & Technology
• Health & Medicine

3 ways we're helping teenagers and young adults with cancer

Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them. Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them.

18 April 2023